v3.21.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Hman Group holdings Inc and subsidiaries
Common Stock
Hman Group holdings Inc and subsidiaries
Treasury Stock
Hman Group holdings Inc and subsidiaries
Additional Paid-in Capital
Hman Group holdings Inc and subsidiaries
Accumulated deficit
Hman Group holdings Inc and subsidiaries
Accumulated Other Comprehensive (Loss)
Hman Group holdings Inc and subsidiaries
Additional Paid-in Capital
Accumulated deficit
Total
Balance at Dec. 30, 2017 $ 5,000 $ (540,000) $ 552,053,000 $ 2,422,000 $ (26,537,000) $ 527,403,000      
Balance at beginning (in shares) at Dec. 30, 2017 547,000 (1,000)              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income - basic and diluted       (58,681,000)   (58,681,000)      
Stock-based compensation     1,590,000     1,590,000      
Change in cumulative foreign currency translation adjustment         (11,053,000) (11,053,000)      
Balance at Dec. 29, 2018 $ 5,000 $ (4,320,000) 553,843,000 (61,871,000) (37,590,000) 450,067,000      
Balance at ending (in shares) at Dec. 29, 2018 547,000 (5,000)              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income - basic and diluted       (85,479,000)   (85,479,000)      
Stock-based compensation     2,981,000     2,981,000      
Change in cumulative foreign currency translation adjustment         5,550,000 5,550,000      
Balance at Dec. 28, 2019 $ 5,000 $ (4,320,000) 557,674,000 (147,350,000) (32,040,000) 373,969,000      
Balance at ending (in shares) at Dec. 28, 2019 548,000 (5,000)              
Balance at Dec. 31, 2018             $ 306 $ 0 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income - basic and diluted             0 0 0
Balance at Dec. 31, 2019             306 0 0
Balance at Dec. 28, 2019 $ 5,000 $ (4,320,000) 557,674,000 (147,350,000) (32,040,000) 373,969,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income - basic and diluted       (14,804,000)   (14,804,000)      
Stock-based compensation     1,145,000     1,145,000      
Restricted shares issued (in shares) 1,000                
Change in cumulative foreign currency translation adjustment         (11,213,000) (11,213,000)      
Balance at Mar. 28, 2020 $ 5,000 $ (4,320,000) 558,819,000 (162,154,000) (43,253,000) 349,097,000      
Balance at ending (in shares) at Mar. 28, 2020 549,000 (5,000)              
Balance at Dec. 28, 2019 $ 5,000 $ (4,320,000) 557,674,000 (147,350,000) (32,040,000) 373,969,000      
Balance at beginning (in shares) at Dec. 28, 2019 548,000 (5,000)              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income - basic and diluted       (24,499,000)   (24,499,000)      
Stock-based compensation     5,125,000     $ 5,125,000      
Proceeds from sale of common stock (in shares)           7,333      
Restricted shares issued (in shares) 1,000                
Change in cumulative foreign currency translation adjustment         2,652,000 $ 2,652,000      
Balance at Dec. 26, 2020 $ 5,000 $ (4,320,000) 570,139,000 (171,849,000) (29,388,000) 364,587,000      
Balance at ending (in shares) at Dec. 26, 2020 556,000 (5,000)              
Balance at Dec. 31, 2019             306 0 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income - basic and diluted             0 0 0
Balance at Mar. 31, 2020             306 0 0
Balance at Dec. 31, 2019             306 0 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income - basic and diluted             0 (28,890,395) (28,890,395)
Balance at Dec. 31, 2020             33,888,383 (28,890,395) 5,000,010
Balance at Dec. 26, 2020 $ 5,000 $ (4,320,000) 570,139,000 (171,849,000) (29,388,000) 364,587,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income - basic and diluted       (8,970,000)   (8,970,000)      
Stock-based compensation     1,741,000     1,741,000      
Restricted shares issued     1,643,000     1,643,000      
Proceeds from sale of common stock (in shares) 2,000                
Change in cumulative foreign currency translation adjustment         2,473,000 2,473,000      
Balance at Mar. 27, 2021 $ 5,000 $ (4,320,000) $ 573,523,000 $ (180,819,000) $ (26,915,000) $ 361,474,000      
Balance at ending (in shares) at Mar. 27, 2021 558,000 (5,000)              
Balance at Dec. 31, 2020             33,888,383 (28,890,395) 5,000,010
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income - basic and diluted             0 10,719,999 10,719,999
Balance at Mar. 31, 2021             $ 23,168,492 $ (18,170,396) $ 5,000,010